BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM
Original Article from The New England Journal of Medicine — BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Original Article from The New England Journal of Medicine — BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
This EACCME-accredited webinar will cover chronic kidney disease in cardio-renal-metabolic patients and management in primary care.
The OncoAlert Newsletter is now out for June 23-29, 2023
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is now out for June 23-29, 2023
Sculptor Håkon Anton Fagerås has created a statue of Cecilie, a mother of three, who was diagnosed with incurable breast cancer at the age of…
Lo strumento sarà testato in uno studio clinico che comincerà a reclutare le pazienti nell’ultimo quadrimestre del 2024 in tre Paesi.
Sculptor Håkon Anton Fagerås has created a statue of Cecilie, a mother of three, who was diagnosed with incurable breast cancer at the age of…
The OncoAlert Newsletter is now out for June 23-29, 2023
Using a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial presented at…